pirinixic acid has been researched along with thioacetamide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| D'Atri, G; Galimberti, E; Gomarasca, P; Kritchevsky, D; Sirtori, CR | 1 |
| Harano, Y; Itoh, Y; Kirishima, T; Minami, M; Morita, A; Nakamura, H; Okanoue, T; Toyama, T; Yamauchi, N | 1 |
4 other study(ies) available for pirinixic acid and thioacetamide
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Clofibrate, pirinixil (BR 931) and WY-14,643 do not affect body cholesterol in Sprague-Dawley rats.
Topics: Animals; Anticholesteremic Agents; Aorta; Cholesterol; Cholesterol, Dietary; Clofibrate; Drug Evaluation, Preclinical; Intestinal Mucosa; Kidney; Liver; Lung; Male; Myocardium; Pyrimidines; Rats; Spleen; Thioacetamide | 1980 |
PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats.
Topics: Animals; Antioxidants; Blotting, Northern; Catalase; Densitometry; Fenofibrate; Fibrosis; Hydrogen Peroxide; Ligands; Liver; Liver Cirrhosis; Male; Models, Biological; Oxidative Stress; Peroxisome Proliferators; PPAR alpha; Pyrimidines; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Superoxide Dismutase; Thioacetamide | 2004 |